+82.7%
MRVL vs CVS
+5.1%
+77.7%
-49.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CVS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.1% | -12.5% | +5.4% | -8.3% |
| 7D | -36.5% | -11.1% | -25.4% | -37.1% |
| 30D | -41.1% | -7.4% | -33.6% | -41.1% |
| 3M | -26.9% | -22.9% | -4.0% | -28.5% |
| 6M | -2.3% | -1.2% | -1.1% | -3.8% |
| YTD | +88.4% | +3.9% | +84.5% | +85.4% |
| 1Y | +82.7% | +5.6% | +77.2% | +85.1% |
| All | +82.7% | +5.1% | +77.7% | +85.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CVS.
Daily Out/Under-Performance
Portfolio return minus CVS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CVS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CVS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling